Gene Symbol | Gene ID | Gene Info |
---|---|---|
HOXA13
|
ENSG00000106031.6 | homeobox A13 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_27238864_27239218 | HOXA13 | 684 | 0.336609 | 0.61 | 8.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_100862555_100862740 | 2.12 |
TRIM14 |
tripartite motif containing 14 |
7804 |
0.19 |
chr9_100692681_100693016 | 2.04 |
C9orf156 |
chromosome 9 open reading frame 156 |
7996 |
0.15 |
chr1_116534434_116534585 | 2.01 |
SLC22A15 |
solute carrier family 22, member 15 |
15274 |
0.22 |
chr2_26018392_26018619 | 1.84 |
ASXL2 |
additional sex combs like 2 (Drosophila) |
15327 |
0.23 |
chr3_71410535_71410686 | 1.84 |
FOXP1 |
forkhead box P1 |
56699 |
0.15 |
chr7_50355659_50355810 | 1.77 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
7416 |
0.3 |
chr19_39029001_39029486 | 1.71 |
AC067969.2 |
|
1475 |
0.28 |
chr16_53492869_53493169 | 1.68 |
RBL2 |
retinoblastoma-like 2 (p130) |
9031 |
0.16 |
chr14_66393765_66394075 | 1.62 |
CTD-2014B16.3 |
Uncharacterized protein |
77321 |
0.11 |
chr12_65061325_65061525 | 1.61 |
RP11-338E21.3 |
|
12626 |
0.13 |
chr3_42430115_42430266 | 1.59 |
LYZL4 |
lysozyme-like 4 |
21860 |
0.18 |
chr15_38965720_38965889 | 1.56 |
C15orf53 |
chromosome 15 open reading frame 53 |
22995 |
0.24 |
chr16_79317454_79317605 | 1.56 |
ENSG00000222244 |
. |
19178 |
0.28 |
chr17_66250172_66250736 | 1.55 |
AMZ2 |
archaelysin family metallopeptidase 2 |
4126 |
0.18 |
chr5_56146335_56146486 | 1.53 |
ENSG00000238717 |
. |
6565 |
0.17 |
chr13_99923034_99923297 | 1.53 |
GPR18 |
G protein-coupled receptor 18 |
9167 |
0.2 |
chr10_26776684_26776954 | 1.51 |
ENSG00000199733 |
. |
21699 |
0.23 |
chr20_47786456_47786607 | 1.50 |
STAU1 |
staufen double-stranded RNA binding protein 1 |
4269 |
0.24 |
chr12_21766880_21767202 | 1.50 |
GYS2 |
glycogen synthase 2 (liver) |
9260 |
0.2 |
chr6_91124113_91124295 | 1.48 |
ENSG00000252676 |
. |
32287 |
0.22 |
chr8_27237001_27237352 | 1.44 |
PTK2B |
protein tyrosine kinase 2 beta |
992 |
0.62 |
chr3_56711954_56712231 | 1.43 |
FAM208A |
family with sequence similarity 208, member A |
4953 |
0.31 |
chr21_43845679_43846098 | 1.43 |
ENSG00000252619 |
. |
8186 |
0.14 |
chr2_198165840_198166224 | 1.43 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
1211 |
0.44 |
chr5_148732689_148732840 | 1.41 |
GRPEL2-AS1 |
GRPEL2 atnisense RNA 1 |
4441 |
0.13 |
chr7_98980002_98980160 | 1.41 |
ARPC1B |
actin related protein 2/3 complex, subunit 1B, 41kDa |
7728 |
0.12 |
chr1_167407962_167408153 | 1.40 |
RP11-104L21.2 |
|
19841 |
0.19 |
chr2_135077495_135077679 | 1.40 |
MGAT5 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
65757 |
0.13 |
chr12_48219359_48219668 | 1.40 |
HDAC7 |
histone deacetylase 7 |
5118 |
0.18 |
chr5_130731338_130731489 | 1.40 |
CDC42SE2 |
CDC42 small effector 2 |
10114 |
0.3 |
chr7_50460410_50460762 | 1.38 |
ENSG00000200815 |
. |
42492 |
0.16 |
chr5_56031342_56031701 | 1.37 |
MAP3K1 |
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
79880 |
0.09 |
chr10_6968378_6968598 | 1.37 |
PRKCQ |
protein kinase C, theta |
346225 |
0.01 |
chr1_29252967_29253119 | 1.37 |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
11952 |
0.18 |
chr1_226892456_226892690 | 1.35 |
ITPKB-IT1 |
ITPKB intronic transcript 1 (non-protein coding) |
29805 |
0.16 |
chr5_39204791_39205314 | 1.35 |
FYB |
FYN binding protein |
1923 |
0.46 |
chr1_161888466_161888711 | 1.33 |
OLFML2B |
olfactomedin-like 2B |
66434 |
0.1 |
chr2_32036582_32036828 | 1.33 |
ENSG00000238448 |
. |
1348 |
0.49 |
chr16_27184587_27184738 | 1.33 |
KDM8 |
lysine (K)-specific demethylase 8 |
30145 |
0.17 |
chr2_28836401_28836726 | 1.33 |
PLB1 |
phospholipase B1 |
11777 |
0.21 |
chr12_12633904_12634353 | 1.33 |
DUSP16 |
dual specificity phosphatase 16 |
39931 |
0.17 |
chr15_38903564_38903715 | 1.33 |
RASGRP1 |
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
45863 |
0.15 |
chr16_28155907_28156089 | 1.32 |
XPO6 |
exportin 6 |
25224 |
0.16 |
chr5_55983823_55983974 | 1.32 |
AC022431.2 |
Homo sapiens uncharacterized LOC101928448 (LOC101928448), mRNA. |
81839 |
0.09 |
chr14_61798870_61799021 | 1.32 |
PRKCH |
protein kinase C, eta |
5314 |
0.22 |
chr20_8001461_8001765 | 1.32 |
RP5-971N18.3 |
|
1064 |
0.41 |
chr2_191380853_191381289 | 1.29 |
TMEM194B |
transmembrane protein 194B |
18012 |
0.15 |
chr8_66894110_66894261 | 1.29 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
39610 |
0.2 |
chr20_40238845_40239072 | 1.28 |
CHD6 |
chromodomain helicase DNA binding protein 6 |
4454 |
0.29 |
chr16_28156208_28156427 | 1.28 |
XPO6 |
exportin 6 |
24905 |
0.16 |
chr6_489632_490047 | 1.28 |
RP1-20B11.2 |
|
34332 |
0.22 |
chr6_7127551_7127702 | 1.28 |
RREB1 |
ras responsive element binding protein 1 |
11852 |
0.22 |
chr9_5337086_5337299 | 1.27 |
RLN1 |
relaxin 1 |
2681 |
0.31 |
chr4_99585470_99585621 | 1.27 |
RP11-1299A16.3 |
|
5490 |
0.24 |
chr10_111820172_111820458 | 1.26 |
ADD3 |
adducin 3 (gamma) |
52593 |
0.13 |
chr12_93821027_93821233 | 1.26 |
UBE2N |
ubiquitin-conjugating enzyme E2N |
13902 |
0.15 |
chr9_101854958_101855213 | 1.26 |
TGFBR1 |
transforming growth factor, beta receptor 1 |
11235 |
0.23 |
chr5_131153566_131153717 | 1.25 |
FNIP1 |
folliculin interacting protein 1 |
20931 |
0.19 |
chr9_92081450_92081888 | 1.25 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
10801 |
0.24 |
chr14_61795247_61795429 | 1.25 |
PRKCH |
protein kinase C, eta |
1707 |
0.37 |
chr7_38353037_38353188 | 1.25 |
STARD3NL |
STARD3 N-terminal like |
135115 |
0.05 |
chr6_88117391_88117588 | 1.24 |
C6ORF165 |
UPF0704 protein C6orf165 |
212 |
0.93 |
chr9_37575768_37575986 | 1.24 |
FBXO10 |
F-box protein 10 |
373 |
0.85 |
chr11_47787849_47788148 | 1.24 |
FNBP4 |
formin binding protein 4 |
855 |
0.51 |
chr4_108956831_108956982 | 1.23 |
HADH |
hydroxyacyl-CoA dehydrogenase |
31115 |
0.18 |
chr1_169657845_169658007 | 1.23 |
SELL |
selectin L |
22913 |
0.17 |
chrX_3624605_3624902 | 1.23 |
PRKX |
protein kinase, X-linked |
6896 |
0.24 |
chr8_82015786_82015967 | 1.23 |
PAG1 |
phosphoprotein associated with glycosphingolipid microdomains 1 |
8427 |
0.3 |
chrX_128905631_128905820 | 1.22 |
SASH3 |
SAM and SH3 domain containing 3 |
8235 |
0.2 |
chr2_242045253_242045514 | 1.21 |
MTERFD2 |
MTERF domain containing 2 |
3636 |
0.18 |
chr22_23131538_23131788 | 1.21 |
ENSG00000207833 |
. |
3314 |
0.06 |
chr12_111017990_111018194 | 1.21 |
PPTC7 |
PTC7 protein phosphatase homolog (S. cerevisiae) |
3033 |
0.21 |
chr14_71456737_71456890 | 1.21 |
PCNX |
pecanex homolog (Drosophila) |
22935 |
0.27 |
chr13_75870281_75870432 | 1.21 |
TBC1D4 |
TBC1 domain family, member 4 |
45311 |
0.17 |
chr1_160673770_160673921 | 1.20 |
CD48 |
CD48 molecule |
7748 |
0.16 |
chr3_20202024_20202233 | 1.20 |
SGOL1-AS1 |
SGOL1 antisense RNA 1 |
13608 |
0.16 |
chr3_46007058_46007478 | 1.20 |
FYCO1 |
FYVE and coiled-coil domain containing 1 |
7115 |
0.18 |
chr14_39638697_39638947 | 1.20 |
TRAPPC6B |
trafficking protein particle complex 6B |
704 |
0.63 |
chr12_92798575_92798768 | 1.19 |
RP11-693J15.4 |
|
16636 |
0.18 |
chr8_101507624_101507831 | 1.19 |
KB-1615E4.3 |
|
2971 |
0.24 |
chr1_18977776_18977927 | 1.19 |
PAX7 |
paired box 7 |
19833 |
0.26 |
chr3_56951565_56952044 | 1.19 |
ARHGEF3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
1305 |
0.52 |
chr8_2079390_2079571 | 1.18 |
MYOM2 |
myomesin 2 |
86296 |
0.1 |
chr14_23004308_23004495 | 1.18 |
TRAJ15 |
T cell receptor alpha joining 15 |
5821 |
0.12 |
chr1_111759730_111759903 | 1.18 |
CHI3L2 |
chitinase 3-like 2 |
9822 |
0.13 |
chr17_37957167_37957469 | 1.18 |
IKZF3 |
IKAROS family zinc finger 3 (Aiolos) |
22840 |
0.13 |
chr11_94896300_94896477 | 1.18 |
RP11-712B9.2 |
|
11478 |
0.24 |
chr1_89126147_89126298 | 1.18 |
PKN2 |
protein kinase N2 |
23683 |
0.21 |
chr10_17273060_17273387 | 1.17 |
VIM |
vimentin |
615 |
0.58 |
chr11_94989224_94989507 | 1.17 |
RP11-712B9.2 |
|
23630 |
0.21 |
chr14_106691102_106691449 | 1.17 |
IGHV3-21 |
immunoglobulin heavy variable 3-21 |
928 |
0.23 |
chrX_65120799_65120950 | 1.16 |
RP6-159A1.3 |
|
98719 |
0.08 |
chr12_71116257_71116408 | 1.16 |
PTPRR |
protein tyrosine phosphatase, receptor type, R |
32041 |
0.22 |
chr12_55430558_55430833 | 1.16 |
NEUROD4 |
neuronal differentiation 4 |
16966 |
0.21 |
chr5_156969848_156970007 | 1.16 |
AC106801.1 |
|
23045 |
0.14 |
chr1_179269215_179269372 | 1.15 |
SOAT1 |
sterol O-acyltransferase 1 |
5838 |
0.22 |
chr15_63964059_63964210 | 1.15 |
RP11-317G6.1 |
|
3211 |
0.25 |
chr17_25625280_25625431 | 1.15 |
WSB1 |
WD repeat and SOCS box containing 1 |
3983 |
0.26 |
chr12_96792061_96792212 | 1.15 |
CDK17 |
cyclin-dependent kinase 17 |
1006 |
0.57 |
chr3_113265049_113265200 | 1.15 |
SIDT1 |
SID1 transmembrane family, member 1 |
13906 |
0.16 |
chr12_15108155_15108306 | 1.14 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
4145 |
0.19 |
chr10_11215563_11215850 | 1.13 |
RP3-323N1.2 |
|
2367 |
0.33 |
chr15_93357238_93357416 | 1.13 |
FAM174B |
family with sequence similarity 174, member B |
4299 |
0.19 |
chr12_104875970_104876121 | 1.13 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
25266 |
0.23 |
chr7_143899399_143899550 | 1.13 |
RP4-545C24.1 |
|
5309 |
0.12 |
chr6_154561758_154561967 | 1.12 |
IPCEF1 |
interaction protein for cytohesin exchange factors 1 |
6128 |
0.33 |
chr1_42447591_42447742 | 1.12 |
HIVEP3 |
human immunodeficiency virus type I enhancer binding protein 3 |
63288 |
0.14 |
chr7_150345472_150345623 | 1.12 |
GIMAP6 |
GTPase, IMAP family member 6 |
16074 |
0.17 |
chr3_152940379_152940533 | 1.11 |
ENSG00000265813 |
. |
22650 |
0.22 |
chr2_203539531_203539699 | 1.11 |
FAM117B |
family with sequence similarity 117, member B |
39704 |
0.2 |
chr1_209928684_209929195 | 1.11 |
TRAF3IP3 |
TRAF3 interacting protein 3 |
438 |
0.78 |
chr10_32619705_32619856 | 1.11 |
RP11-135A24.4 |
|
15647 |
0.13 |
chr17_4634435_4634586 | 1.10 |
MED11 |
mediator complex subunit 11 |
213 |
0.81 |
chr22_37695641_37695792 | 1.10 |
CYTH4 |
cytohesin 4 |
10293 |
0.17 |
chr1_40863540_40863744 | 1.10 |
SMAP2 |
small ArfGAP2 |
1135 |
0.47 |
chr21_36415261_36415514 | 1.10 |
RUNX1 |
runt-related transcription factor 1 |
6075 |
0.34 |
chr2_198060963_198061183 | 1.09 |
AC013264.2 |
|
1642 |
0.33 |
chr8_30242798_30243102 | 1.09 |
RBPMS-AS1 |
RBPMS antisense RNA 1 |
33 |
0.75 |
chr3_31608406_31608572 | 1.09 |
STT3B |
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
34207 |
0.23 |
chr6_135343967_135344158 | 1.09 |
HBS1L |
HBS1-like (S. cerevisiae) |
4232 |
0.25 |
chr21_32817963_32818114 | 1.09 |
TIAM1 |
T-cell lymphoma invasion and metastasis 1 |
101444 |
0.07 |
chr2_242799147_242799446 | 1.09 |
PDCD1 |
programmed cell death 1 |
1764 |
0.22 |
chr3_9775331_9775482 | 1.09 |
BRPF1 |
bromodomain and PHD finger containing, 1 |
408 |
0.75 |
chr7_26238411_26238603 | 1.09 |
HNRNPA2B1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
1859 |
0.27 |
chr9_92097820_92097971 | 1.08 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
3090 |
0.3 |
chr6_166830627_166830814 | 1.08 |
RP1-168L15.5 |
|
34043 |
0.13 |
chr12_68025335_68025706 | 1.07 |
DYRK2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
16598 |
0.25 |
chr6_106505003_106505293 | 1.07 |
PRDM1 |
PR domain containing 1, with ZNF domain |
29047 |
0.2 |
chr2_204852803_204853093 | 1.07 |
ICOS |
inducible T-cell co-stimulator |
51445 |
0.17 |
chr2_99325700_99325976 | 1.07 |
MGAT4A |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A |
17321 |
0.22 |
chr4_36242852_36243101 | 1.07 |
ARAP2 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
2585 |
0.28 |
chr3_107695096_107695544 | 1.07 |
CD47 |
CD47 molecule |
81888 |
0.11 |
chr2_36468391_36468542 | 1.07 |
CRIM1 |
cysteine rich transmembrane BMP regulator 1 (chordin-like) |
114603 |
0.07 |
chr2_95401875_95402026 | 1.07 |
ENSG00000212140 |
. |
110434 |
0.06 |
chr7_3023270_3023421 | 1.06 |
ENSG00000201794 |
. |
15383 |
0.21 |
chr17_46469509_46469660 | 1.06 |
ENSG00000200538 |
. |
9636 |
0.15 |
chr9_5531438_5531729 | 1.06 |
PDCD1LG2 |
programmed cell death 1 ligand 2 |
21013 |
0.22 |
chr15_55548229_55548380 | 1.06 |
RAB27A |
RAB27A, member RAS oncogene family |
7071 |
0.22 |
chr19_12442304_12442683 | 1.06 |
ZNF563 |
zinc finger protein 563 |
1813 |
0.27 |
chr12_915641_915948 | 1.06 |
ENSG00000221439 |
. |
25495 |
0.19 |
chr7_151840900_151841202 | 1.06 |
KMT2C |
lysine (K)-specific methyltransferase 2C |
1167 |
0.5 |
chr20_57832790_57833213 | 1.06 |
EDN3 |
endothelin 3 |
42481 |
0.16 |
chr4_26883824_26883975 | 1.05 |
STIM2 |
stromal interaction molecule 2 |
20818 |
0.22 |
chr2_231193751_231193977 | 1.05 |
SP140L |
SP140 nuclear body protein-like |
1879 |
0.42 |
chr15_41835991_41836329 | 1.05 |
RPAP1 |
RNA polymerase II associated protein 1 |
288 |
0.88 |
chr21_34673276_34673439 | 1.05 |
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
23377 |
0.13 |
chr1_235484471_235484652 | 1.05 |
GGPS1 |
geranylgeranyl diphosphate synthase 1 |
6104 |
0.2 |
chr14_98643617_98643768 | 1.04 |
ENSG00000222066 |
. |
154395 |
0.04 |
chr7_106510152_106510317 | 1.04 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
4310 |
0.31 |
chr7_115875901_115876112 | 1.04 |
AC073130.3 |
|
3299 |
0.27 |
chr15_70849476_70849729 | 1.04 |
UACA |
uveal autoantigen with coiled-coil domains and ankyrin repeats |
145018 |
0.05 |
chr2_198150239_198150434 | 1.04 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
16907 |
0.16 |
chr19_48103347_48103498 | 1.04 |
GLTSCR1 |
glioma tumor suppressor candidate region gene 1 |
8031 |
0.14 |
chr10_32749220_32749452 | 1.04 |
CCDC7 |
coiled-coil domain containing 7 |
8787 |
0.22 |
chr17_62965440_62965774 | 1.04 |
AMZ2P1 |
archaelysin family metallopeptidase 2 pseudogene 1 |
4028 |
0.17 |
chr4_170580974_170581158 | 1.04 |
CLCN3 |
chloride channel, voltage-sensitive 3 |
147 |
0.97 |
chr4_143406373_143406524 | 1.04 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
10887 |
0.33 |
chr18_43265926_43266136 | 1.03 |
SLC14A2 |
solute carrier family 14 (urea transporter), member 2 |
19924 |
0.17 |
chr3_25697510_25697827 | 1.03 |
TOP2B |
topoisomerase (DNA) II beta 180kDa |
8120 |
0.21 |
chr11_128569330_128569763 | 1.03 |
SENCR |
smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA |
3628 |
0.22 |
chr7_72298254_72298561 | 1.03 |
TYW1B |
tRNA-yW synthesizing protein 1 homolog B (S. cerevisiae) |
346 |
0.78 |
chr5_87552656_87552807 | 1.03 |
TMEM161B |
transmembrane protein 161B |
11908 |
0.19 |
chr1_116865589_116865827 | 1.03 |
ENSG00000221040 |
. |
44480 |
0.13 |
chr22_23269052_23269214 | 1.03 |
IGLJ7 |
immunoglobulin lambda joining 7 |
5571 |
0.07 |
chr2_198132765_198133005 | 1.03 |
ANKRD44-IT1 |
ANKRD44 intronic transcript 1 (non-protein coding) |
34358 |
0.14 |
chr7_7297595_7297777 | 1.02 |
C1GALT1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
23735 |
0.22 |
chr10_75193848_75193999 | 1.02 |
MSS51 |
MSS51 mitochondrial translational activator |
604 |
0.61 |
chr10_73866536_73866921 | 1.02 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
17938 |
0.2 |
chr2_233948147_233948470 | 1.02 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
23119 |
0.17 |
chr5_65162520_65162757 | 1.02 |
ERBB2IP |
erbb2 interacting protein |
59665 |
0.12 |
chr1_193446877_193447028 | 1.02 |
ENSG00000252241 |
. |
254122 |
0.02 |
chr16_50790859_50791251 | 1.02 |
CYLD |
cylindromatosis (turban tumor syndrome) |
7595 |
0.12 |
chr2_235125609_235126070 | 1.01 |
SPP2 |
secreted phosphoprotein 2, 24kDa |
166408 |
0.04 |
chr7_37355725_37356299 | 1.01 |
ELMO1 |
engulfment and cell motility 1 |
26355 |
0.19 |
chr9_92141364_92141857 | 1.01 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
28565 |
0.19 |
chr4_109010070_109010221 | 1.01 |
LEF1 |
lymphoid enhancer-binding factor 1 |
77312 |
0.09 |
chr8_19574598_19574749 | 1.01 |
CSGALNACT1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
34401 |
0.22 |
chr1_169764624_169764835 | 1.01 |
C1orf112 |
chromosome 1 open reading frame 112 |
179 |
0.84 |
chr8_141580949_141581161 | 1.01 |
AGO2 |
argonaute RISC catalytic component 2 |
34932 |
0.17 |
chr3_141270944_141271180 | 1.01 |
RASA2-IT1 |
RASA2 intronic transcript 1 (non-protein coding) |
27087 |
0.21 |
chr12_9177186_9177502 | 1.01 |
RP11-259O18.4 |
|
28182 |
0.13 |
chr10_17548622_17548773 | 1.01 |
ST8SIA6 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
52368 |
0.13 |
chr16_89179985_89180136 | 1.01 |
CTD-2555A7.3 |
|
1627 |
0.33 |
chr3_59904477_59904972 | 1.00 |
NPCDR1 |
nasopharyngeal carcinoma, down-regulated 1 |
52859 |
0.19 |
chr22_30704308_30704459 | 1.00 |
TBC1D10A |
TBC1 domain family, member 10A |
504 |
0.64 |
chr16_16054661_16054838 | 1.00 |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
11315 |
0.21 |
chrX_135710444_135710648 | 1.00 |
ENSG00000233093 |
. |
11156 |
0.16 |
chr10_16480889_16481220 | 1.00 |
PTER |
phosphotriesterase related |
2071 |
0.36 |
chr2_55278350_55278727 | 1.00 |
RTN4 |
reticulon 4 |
574 |
0.78 |
chr2_175615602_175615812 | 1.00 |
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
13433 |
0.23 |
chr16_30339211_30339430 | 1.00 |
RP11-347C12.2 |
|
7055 |
0.1 |
chr2_162807979_162808245 | 1.00 |
ENSG00000253046 |
. |
32820 |
0.21 |
chr9_104330443_104330594 | 1.00 |
ENSG00000265068 |
. |
18465 |
0.16 |
chr2_174756889_174757040 | 1.00 |
SP3 |
Sp3 transcription factor |
71983 |
0.13 |
chr8_133768369_133768538 | 1.00 |
TMEM71 |
transmembrane protein 71 |
4341 |
0.22 |
chr21_38770615_38770766 | 1.00 |
DYRK1A |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
20517 |
0.2 |
chr1_194022845_194023072 | 1.00 |
ENSG00000252241 |
. |
321884 |
0.01 |
chr3_179168564_179168715 | 1.00 |
GNB4 |
guanine nucleotide binding protein (G protein), beta polypeptide 4 |
294 |
0.9 |
chr2_25625880_25626031 | 1.00 |
AC104699.1 |
|
18031 |
0.22 |
chr12_55130676_55130890 | 0.99 |
DCD |
dermcidin |
88506 |
0.07 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.4 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.7 | 2.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 2.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.5 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 1.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.5 | 2.5 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.5 | 1.9 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.5 | 1.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.4 | 3.5 | GO:0007172 | signal complex assembly(GO:0007172) |
0.4 | 0.9 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.4 | 2.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.4 | 1.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.4 | 1.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.4 | 1.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.4 | 1.6 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.4 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 1.2 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.4 | 0.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.4 | 0.4 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.4 | 2.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.4 | 0.4 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 1.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.7 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.3 | 0.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.3 | 1.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 1.6 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 0.3 | GO:0016556 | mRNA modification(GO:0016556) |
0.3 | 0.6 | GO:0002517 | T cell tolerance induction(GO:0002517) regulation of T cell tolerance induction(GO:0002664) positive regulation of T cell tolerance induction(GO:0002666) |
0.3 | 1.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 0.6 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.3 | 0.9 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.3 | 0.9 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.3 | 0.9 | GO:0090009 | primitive streak formation(GO:0090009) |
0.3 | 0.9 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.3 | 0.9 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.3 | 0.9 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
0.3 | 1.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 2.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 0.5 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.3 | 0.8 | GO:0001821 | histamine secretion(GO:0001821) |
0.3 | 0.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.3 | 0.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.3 | 0.8 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 1.0 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.3 | 1.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.3 | 0.8 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 1.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 1.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.9 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.2 | 0.2 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 0.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.2 | 0.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.2 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 1.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 2.4 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.2 | 4.1 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.9 | GO:0072133 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.2 | 0.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.6 | GO:0070602 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.2 | 1.1 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.2 | 0.2 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.2 | 1.7 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 0.4 | GO:0070340 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
0.2 | 0.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 0.6 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.6 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.2 | 2.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.2 | 0.8 | GO:1904376 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.2 | 0.6 | GO:1904358 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.2 | 0.2 | GO:0033087 | immature T cell proliferation(GO:0033079) immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation(GO:0033083) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 1.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.2 | 1.7 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 0.4 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.6 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.2 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 2.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 11.1 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 0.8 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 0.4 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.2 | 0.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.4 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.2 | 1.7 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.2 | 0.7 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.9 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.6 | GO:0072600 | protein targeting to Golgi(GO:0000042) establishment of protein localization to Golgi(GO:0072600) |
0.2 | 0.9 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
0.2 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 0.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.2 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 0.2 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.2 | 0.5 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.2 | 0.7 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.2 | 0.5 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.5 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 1.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.2 | 1.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 0.5 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 0.5 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.2 | 0.2 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.2 | 0.5 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.2 | 0.3 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 0.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.2 | 0.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.2 | 0.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.2 | 0.8 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.2 | 0.7 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.3 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.2 | 0.5 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.2 | 0.3 | GO:0045066 | regulatory T cell differentiation(GO:0045066) |
0.2 | 0.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.2 | 0.5 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.2 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.2 | 1.1 | GO:0002839 | regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) |
0.2 | 1.4 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.6 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.2 | 0.5 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 1.1 | GO:0036314 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
0.2 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.5 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 1.4 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi vesicle budding(GO:0048194) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.2 | 1.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.1 | 0.6 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.3 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 1.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.4 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.1 | GO:0017085 | response to insecticide(GO:0017085) |
0.1 | 0.6 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.6 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.0 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.1 | 0.8 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.3 | GO:0043414 | macromolecule methylation(GO:0043414) |
0.1 | 0.4 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.1 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 0.1 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.3 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.8 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.4 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.7 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.4 | GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.1 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.5 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.1 | 0.4 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 3.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0044091 | membrane biogenesis(GO:0044091) |
0.1 | 0.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.1 | 0.4 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 0.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.3 | GO:2000189 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 1.8 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
0.1 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.1 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 1.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 0.5 | GO:0021612 | facial nerve development(GO:0021561) cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) anatomical structure arrangement(GO:0048532) |
0.1 | 0.4 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.1 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.2 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.1 | 1.6 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 0.6 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 0.5 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.6 | GO:0001562 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.1 | 0.5 | GO:0048488 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.1 | 1.2 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.4 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.1 | 0.1 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.1 | 0.8 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 1.5 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.2 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.2 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 1.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 1.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.8 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:1901799 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) negative regulation of proteasomal protein catabolic process(GO:1901799) negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.1 | 0.2 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 1.0 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.1 | 0.1 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
0.1 | 0.1 | GO:0045346 | regulation of MHC class II biosynthetic process(GO:0045346) |
0.1 | 0.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 2.0 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.3 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 2.6 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.1 | 1.9 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.1 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.1 | 2.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.2 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 1.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.5 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 2.6 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.4 | GO:0051307 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.1 | 1.1 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.3 | GO:0009452 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.4 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.1 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.2 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.2 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 0.2 | GO:0061054 | dermatome development(GO:0061054) |
0.1 | 0.7 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.5 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.1 | 0.5 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.2 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.5 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 3.2 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.5 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.1 | 0.3 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.4 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.1 | 0.2 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 3.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 8.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.1 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.1 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.3 | GO:2000134 | negative regulation of cell cycle G1/S phase transition(GO:1902807) negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.3 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.6 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.5 | GO:0031123 | RNA 3'-end processing(GO:0031123) |
0.1 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 0.1 | GO:0060323 | head morphogenesis(GO:0060323) |
0.1 | 0.4 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 1.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 1.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.3 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.1 | 0.3 | GO:0032653 | regulation of interleukin-10 production(GO:0032653) positive regulation of interleukin-10 production(GO:0032733) |
0.1 | 1.3 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.1 | 0.3 | GO:0016241 | regulation of macroautophagy(GO:0016241) negative regulation of macroautophagy(GO:0016242) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.3 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.1 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0031848 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.1 | 0.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.1 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.1 | 1.7 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.1 | 4.0 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.1 | 0.6 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.2 | GO:0010834 | obsolete telomere maintenance via telomere shortening(GO:0010834) |
0.1 | 0.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 2.3 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.1 | GO:0061029 | hair follicle placode formation(GO:0060789) eyelid development in camera-type eye(GO:0061029) |
0.1 | 2.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
0.1 | 0.3 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.3 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.1 | 1.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.2 | GO:0032641 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.4 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 1.3 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 0.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.6 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 0.1 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.1 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.3 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 0.1 | GO:0009296 | obsolete flagellum assembly(GO:0009296) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 3.9 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.1 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 1.1 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.1 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 2.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.6 | GO:0031269 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 0.2 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 7.7 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.1 | 0.9 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
0.1 | 0.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.2 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.3 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.1 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
0.1 | 0.2 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.5 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.2 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.2 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.1 | GO:0021707 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.9 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 1.0 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.1 | 0.1 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 0.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.1 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.1 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.1 | 0.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.3 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 0.9 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.7 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 1.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 3.4 | GO:1902403 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 0.1 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.1 | 3.5 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.4 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 1.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.2 | GO:0043570 | meiotic mismatch repair(GO:0000710) maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.1 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.1 | 0.1 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.1 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.2 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.2 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.1 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 2.1 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.2 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 7.1 | GO:0006397 | mRNA processing(GO:0006397) |
0.1 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.5 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.5 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.3 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.3 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.1 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.1 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 1.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.1 | GO:0048670 | regulation of collateral sprouting(GO:0048670) |
0.1 | 2.8 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.3 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.2 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.1 | 0.3 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.3 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.2 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) glial cell fate specification(GO:0021780) |
0.1 | 0.3 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
0.1 | 0.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.4 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.4 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.2 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.1 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.1 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.2 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 1.7 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.4 | GO:0071333 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.1 | 1.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.1 | 2.2 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.2 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.5 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
0.1 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.1 | 0.1 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.1 | 1.6 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.1 | 2.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.1 | 0.3 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.1 | 1.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 0.2 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.1 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.1 | 0.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 0.2 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.9 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.1 | 0.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.7 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 metabolic process(GO:0042816) vitamin B6 biosynthetic process(GO:0042819) |
0.1 | 0.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.8 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 3.9 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 0.1 | GO:0032609 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) |
0.1 | 0.2 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.1 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:0019226 | transmission of nerve impulse(GO:0019226) multicellular organismal signaling(GO:0035637) |
0.1 | 1.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.1 | GO:1901216 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.1 | 0.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 0.6 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.1 | 0.1 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.1 | 0.1 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 4.6 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.1 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.4 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0021522 | ventral spinal cord development(GO:0021517) spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.2 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 1.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.1 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.4 | GO:0009304 | tRNA transcription(GO:0009304) |
0.1 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.1 | 1.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.1 | 0.1 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) deoxyribose phosphate catabolic process(GO:0046386) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.7 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.4 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
0.1 | 0.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
0.1 | 0.1 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.5 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.1 | 0.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.3 | GO:0051806 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 0.5 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.3 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.0 | 0.1 | GO:0033131 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.7 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.2 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.3 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.4 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.1 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.0 | 0.2 | GO:1903076 | regulation of establishment of protein localization to plasma membrane(GO:0090003) regulation of protein localization to plasma membrane(GO:1903076) regulation of protein localization to cell periphery(GO:1904375) |
0.0 | 0.2 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.1 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.2 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.0 | 0.4 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.9 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.2 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.2 | GO:0001881 | receptor recycling(GO:0001881) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.7 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.2 | GO:0010506 | regulation of autophagy(GO:0010506) |
0.0 | 0.6 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.0 | 0.0 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.0 | 0.1 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.0 | 0.0 | GO:0032770 | positive regulation of monooxygenase activity(GO:0032770) |
0.0 | 0.3 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.4 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.0 | 0.1 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.6 | GO:0071826 | ribonucleoprotein complex subunit organization(GO:0071826) |
0.0 | 0.4 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.5 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
0.0 | 0.4 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 2.4 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.2 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.6 | GO:1903037 | regulation of T cell activation(GO:0050863) regulation of leukocyte cell-cell adhesion(GO:1903037) |
0.0 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.0 | GO:0001866 | natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) |
0.0 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0010939 | regulation of necrotic cell death(GO:0010939) |
0.0 | 0.3 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.0 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.0 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.0 | 0.2 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.0 | 0.0 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
0.0 | 0.2 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.0 | 0.2 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.0 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.0 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.0 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.3 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
0.0 | 0.0 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.2 | GO:0030146 | obsolete diuresis(GO:0030146) |
0.0 | 0.4 | GO:0000087 | mitotic M phase(GO:0000087) |
0.0 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.0 | 0.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 4.1 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.0 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.0 | 0.3 | GO:0061572 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.0 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 2.7 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 1.6 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.0 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.0 | 0.2 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.3 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.5 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.0 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0070664 | negative regulation of leukocyte proliferation(GO:0070664) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.3 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.1 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.0 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.0 | 0.0 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.0 | 0.1 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.0 | 0.2 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.0 | 0.1 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.0 | 0.2 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.0 | 0.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.3 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 8.7 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.3 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.4 | GO:0017158 | regulation of calcium ion-dependent exocytosis(GO:0017158) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
0.0 | 0.7 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.0 | 0.1 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.0 | 0.1 | GO:0042363 | vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.1 | GO:0045123 | cellular extravasation(GO:0045123) |
0.0 | 0.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.6 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.0 | 0.1 | GO:0009451 | RNA modification(GO:0009451) |
0.0 | 0.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.1 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.3 | GO:0051899 | membrane depolarization(GO:0051899) |
0.0 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.0 | 0.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0006997 | nucleus organization(GO:0006997) |
0.0 | 0.5 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 3.0 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.0 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.0 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
0.0 | 0.7 | GO:0001906 | cell killing(GO:0001906) |
0.0 | 0.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.7 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.0 | 0.2 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) |
0.0 | 0.2 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.1 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.2 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.9 | GO:0030041 | actin filament polymerization(GO:0030041) |
0.0 | 0.0 | GO:0045061 | thymic T cell selection(GO:0045061) |
0.0 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:1905145 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) cellular response to ammonium ion(GO:0071242) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.0 | GO:0001820 | serotonin secretion(GO:0001820) |
0.0 | 0.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.6 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.0 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0034767 | positive regulation of transmembrane transport(GO:0034764) positive regulation of ion transmembrane transport(GO:0034767) |
0.0 | 0.3 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.5 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.2 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.0 | 0.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.1 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 0.0 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.0 | 0.2 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.2 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.0 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.2 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.0 | 0.1 | GO:0042594 | response to starvation(GO:0042594) |
0.0 | 0.0 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.0 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.0 | 0.3 | GO:0001895 | retina homeostasis(GO:0001895) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.1 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.0 | 0.0 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.7 | GO:0042384 | cilium assembly(GO:0042384) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.0 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.0 | GO:0022030 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.0 | 0.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.0 | 0.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) |
0.0 | 0.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 1.7 | GO:0048011 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 0.0 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.0 | 0.0 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
0.0 | 0.0 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.2 | GO:0017156 | calcium ion regulated exocytosis(GO:0017156) |
0.0 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.1 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
0.0 | 0.0 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:0032732 | positive regulation of interleukin-1 production(GO:0032732) |
0.0 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.1 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 0.0 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.0 | 0.1 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.0 | 0.1 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.0 | 0.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 1.0 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.0 | 1.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.0 | GO:0034644 | cellular response to UV(GO:0034644) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.0 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.0 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
0.0 | 0.1 | GO:0018202 | peptidyl-histidine phosphorylation(GO:0018106) peptidyl-histidine modification(GO:0018202) |
0.0 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.0 | 0.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0072170 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.4 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.0 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0072505 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.0 | GO:0001705 | ectoderm formation(GO:0001705) |
0.0 | 0.1 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.2 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 1.7 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.0 | GO:0070227 | lymphocyte apoptotic process(GO:0070227) |
0.0 | 0.1 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.2 | GO:0006885 | regulation of pH(GO:0006885) |
0.0 | 0.1 | GO:0007613 | memory(GO:0007613) |
0.0 | 0.0 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.0 | GO:0006837 | serotonin transport(GO:0006837) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.0 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.3 | GO:0033572 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.0 | 0.1 | GO:0051181 | cofactor transport(GO:0051181) |
0.0 | 0.0 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.0 | 0.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.0 | 0.0 | GO:0045217 | cell junction maintenance(GO:0034331) cellular component maintenance(GO:0043954) cell-cell junction maintenance(GO:0045217) |
0.0 | 0.0 | GO:0010458 | exit from mitosis(GO:0010458) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.0 | 0.0 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.0 | 0.0 | GO:1903792 | negative regulation of anion transport(GO:1903792) |
0.0 | 0.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.0 | 0.0 | GO:0000723 | telomere maintenance(GO:0000723) |
0.0 | 0.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.5 | GO:0007565 | female pregnancy(GO:0007565) |
0.0 | 1.3 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.0 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.0 | 0.0 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.0 | 0.1 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.0 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.0 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.0 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.0 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 0.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) actin-mediated cell contraction(GO:0070252) |
0.0 | 0.1 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.0 | 0.4 | GO:0007605 | sensory perception of sound(GO:0007605) |
0.0 | 0.0 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
0.0 | 0.0 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.0 | GO:0002209 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
0.0 | 0.0 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.0 | 0.1 | GO:0007051 | spindle organization(GO:0007051) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 3.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.4 | 1.9 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.3 | 1.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 0.6 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.3 | 1.8 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 3.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.3 | 1.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.7 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 1.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 3.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 2.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 3.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 1.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 0.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 1.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 2.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 0.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 1.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 1.1 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.2 | 0.4 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.2 | 0.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 2.0 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 0.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.5 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 2.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.2 | 1.2 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 1.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.7 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 1.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 1.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.8 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 0.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 0.6 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.3 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.7 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 4.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 1.2 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.0 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.8 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.1 | 1.4 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.6 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.6 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.1 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.1 | 0.4 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 0.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) contractile ring(GO:0070938) |
0.1 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 1.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.8 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 3.7 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.4 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 2.1 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 1.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.6 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 10.1 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.3 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.1 | 0.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.5 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 1.2 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.1 | 0.1 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.8 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 3.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 3.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.5 | GO:0016605 | PML body(GO:0016605) |
0.1 | 1.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 1.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.3 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.7 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 5.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 1.0 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.1 | 0.3 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 8.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.5 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.4 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 4.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 0.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 1.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 6.4 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 1.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.9 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.1 | 0.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 5.1 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.1 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
0.1 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.1 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.3 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.1 | 0.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.5 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.6 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 0.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.1 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.5 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.1 | 23.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.6 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.3 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.8 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.1 | 1.3 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 1.9 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.0 | 0.0 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.2 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 3.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 3.8 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 0.6 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
0.0 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 2.5 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.8 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.0 | GO:0045259 | proton-transporting ATP synthase complex(GO:0045259) |
0.0 | 2.5 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 1.0 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 0.9 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.0 | GO:0030312 | external encapsulating structure(GO:0030312) external encapsulating structure part(GO:0044462) |
0.0 | 27.7 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.2 | GO:0031672 | A band(GO:0031672) |
0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.7 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.1 | GO:0070820 | tertiary granule(GO:0070820) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.0 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.0 | 0.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0045495 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.0 | 0.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 1.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0042825 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 6.2 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.3 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.6 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 1.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.7 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 0.6 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.5 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 89.4 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.5 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.2 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0005883 | neurofilament(GO:0005883) |
0.0 | 0.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 0.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.1 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 0.3 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 17.1 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 3.9 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 3.0 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 1.2 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 18.2 | GO:0005829 | cytosol(GO:0005829) |
0.0 | 1.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 1.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 7.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.0 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.0 | 0.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 2.0 | GO:0000139 | Golgi membrane(GO:0000139) |
0.0 | 0.1 | GO:0097223 | sperm part(GO:0097223) |
0.0 | 1.4 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.0 | 0.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.0 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 32.6 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.0 | GO:0030118 | clathrin coat(GO:0030118) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 1.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 1.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.5 | 1.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 6.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.4 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 0.7 | GO:0004527 | exonuclease activity(GO:0004527) |
0.3 | 2.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 0.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.3 | 3.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.3 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 1.3 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 1.6 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 0.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.3 | 0.9 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 2.5 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.3 | 0.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 2.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 2.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.2 | 0.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 2.0 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.2 | 0.7 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.2 | 0.7 | GO:0005113 | patched binding(GO:0005113) |
0.2 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.6 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.2 | 0.6 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.8 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 1.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 0.9 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 2.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 0.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.7 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 0.7 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.2 | 1.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 1.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 0.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.2 | 0.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.3 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.9 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 1.2 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 2.0 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.2 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 1.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 6.1 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.2 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.6 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.2 | 2.5 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 0.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 2.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.2 | 1.4 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 2.1 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 0.4 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 1.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 3.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.3 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.1 | 0.3 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 1.8 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.2 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 1.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 1.0 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.5 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.1 | GO:0019959 | C-X-C chemokine binding(GO:0019958) interleukin-8 binding(GO:0019959) |
0.1 | 0.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 1.5 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 0.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.5 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.6 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.8 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.1 | 0.7 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 1.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.6 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 3.9 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.1 | 0.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 1.0 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.3 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.1 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 5.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.3 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.1 | 0.1 | GO:0032558 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.1 | 1.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 3.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.1 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.1 | 2.7 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 2.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.1 | 1.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 0.8 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.3 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.1 | 0.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.8 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.5 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.1 | 0.3 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.7 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 4.9 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 0.5 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.1 | 0.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 4.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.6 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 2.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 2.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.3 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.3 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 3.0 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 0.2 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 1.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 2.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.7 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 1.2 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.1 | 0.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.5 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.6 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.2 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
0.1 | 1.6 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 0.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.1 | 0.3 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 2.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 4.1 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 1.9 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.3 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 0.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 2.5 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 1.7 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.1 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.6 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.8 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 1.4 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.1 | 0.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.6 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.2 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.1 | 0.3 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.6 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 1.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.1 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 1.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.3 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 0.5 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.1 | 0.6 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.1 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.1 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 1.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 1.2 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.9 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 0.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 3.7 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 0.8 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.1 | 0.1 | GO:0004340 | glucokinase activity(GO:0004340) |
0.1 | 0.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.1 | GO:0061630 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.5 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.8 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.0 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.7 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 1.0 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.0 | 26.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 1.3 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 1.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.0 | 0.6 | GO:0005035 | death receptor activity(GO:0005035) |
0.0 | 0.1 | GO:0015184 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 1.1 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.0 | 0.1 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.1 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.0 | 0.5 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.0 | GO:0019956 | chemokine binding(GO:0019956) |
0.0 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.4 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) |
0.0 | 0.9 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) DNA polymerase activity(GO:0034061) |
0.0 | 0.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 2.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.0 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel regulator activity(GO:0016247) channel inhibitor activity(GO:0016248) |
0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 1.4 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.0 | 3.1 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.0 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.0 | 0.5 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.0 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.1 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 1.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 1.3 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.8 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 3.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.0 | 0.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.0 | 2.5 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 2.4 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 4.4 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 3.7 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.0 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.4 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.0 | GO:0010851 | cyclase regulator activity(GO:0010851) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.0 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 6.5 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.0 | 0.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.0 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.0 | 2.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 0.0 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 53.0 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 0.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.9 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.0 | 0.4 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.0 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 0.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.0 | 1.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.0 | 0.1 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.0 | 0.1 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.8 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 5.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 5.7 | GO:0032561 | GTP binding(GO:0005525) guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.0 | 0.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.0 | 0.3 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 2.0 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.6 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) |
0.0 | 0.3 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.0 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.3 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.0 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
0.0 | 0.0 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0048185 | activin binding(GO:0048185) |
0.0 | 0.0 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0080031 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.0 | 0.0 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
0.0 | 0.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0015250 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 7.3 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.1 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.0 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.0 | 1.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.0 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 8.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.3 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 0.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 15.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 4.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 5.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.2 | 2.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 9.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 9.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 2.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 1.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 6.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 5.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 4.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 2.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 1.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 2.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 0.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 3.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 2.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 0.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.1 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 2.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 4.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 3.3 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.9 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 1.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 3.6 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.1 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 0.1 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.0 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.1 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.0 | 0.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 1.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 1.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 1.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.9 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.3 | 9.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 4.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 3.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 3.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 5.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.5 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 2.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.2 | 2.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 2.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 1.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 3.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.2 | 2.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 2.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 3.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.2 | 2.2 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.2 | 4.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.3 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.1 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.6 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 5.2 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 2.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.6 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.1 | 1.7 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 1.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 5.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 2.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 3.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 3.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 9.7 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 1.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.8 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.0 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 4.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 2.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 2.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.2 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.3 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 1.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 1.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.1 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.1 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.3 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 5.5 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 4.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 1.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.9 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 0.8 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.1 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 4.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.1 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.1 | 0.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 4.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 1.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.7 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 2.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 1.1 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.3 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.1 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 1.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 0.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.7 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 1.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.1 | 3.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 0.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 6.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 0.6 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 1.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.0 | 2.1 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 1.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.8 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 1.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.0 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.3 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.0 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.9 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 0.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 1.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 5.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.1 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.4 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.0 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 2.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.0 | 0.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 0.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.1 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 0.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 0.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.0 | 3.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |